EPA for Remission of Autoimmune Small-Vessel Vasculitis
This article at a glance
- In two clinical cases, EPA was recognized to possibly offer support to the long-term remission of autoimmune small vessel vasculitis, when used in combination with methylprednisolone and aspirin.
- The study next addressed the mechanisms whereby this may occur. A potential role for EPA as an adjunct to drug treatment for attenuating the activity of autoimmune ANCA-associated vasculitides deserves to be tested in properly designed trials.